Clinical studies could begin as early as August, subject to regulatory approvals, Pfizer says.
Home » News, Insights & Trends » Business » Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant
Clinical studies could begin as early as August, subject to regulatory approvals, Pfizer says.
Sign up for free or use coupon code 1BW50 for 50% discount on your subscription
Sign up now